Although the abundance ratio of CD5L was not significantly different in both groups, it was previously found to be increased in patients with lung cancer, with its expression correlated to cancer tissues, and CD5L was suggested as a non-invasive biomarker for this type of cancer [38]. This evidence concerns the gene CD5L and lung cancer.